HOME >> MEDICINE >> NEWS
Endocrine Society calls for clinical guidelines on androgens for women

Chevy Chase, MD The Endocrine Society, which represents more than 12,000 endocrinologists who are specially trained to diagnose, treat and conduct basic and clinical research on complex hormonal disorders, today called for new clinical guidelines on the use of androgens in women/female sexual dysfunction. The organization also notes that additional research into androgens and women as well sexual dysfunction in women will help doctors and patients better understand how to diagnose and effectively treat this condition. This announcement comes as Intrinsa--a testosterone skin patch for women--is reviewed by the Food and Drug Administration as a treatment for a specific population of women who suffer from sexual dysfunction.

"Because of the growing recognition of female sexual dysfunction as well as the increase in women seeking treatment, The Endocrine Society is in the early stages of preparing clinical guidelines for the care of these patients," announced Endocrine Society President, Anthony Means, Ph.D. "As new treatments come available, we want to make sure that physicians understand how and when to use them to treat patients. We plan to release our clinical guidelines in 2005."

--Female Sexual Dysfunction--

Female sexual dysfunction affects over 40 percent of women in the United States, according to a 1999 study from The Journal of the American Medical Association. As experts evaluate women with potential sexual interest disorders, there is a growing amount of information to guide them in how to understand, diagnose and treat these problems. Androgens -- hormones like testosterone that produce male characteristics -- are known to be involved in women's arousability, response and intensity and ease of orgasm, as well as in initial spontaneous desire. Androgens are also involved in the active neurovascular smooth muscle response of swelling and increased lubrication and likely affect genital sexual sensitivity. The testoster
'"/>


2-Dec-2004


Page: 1 2 3

Related medicine news :

1. AACC and The Endocrine Society partner to promote patient education
2. ENDO 2005 - The Endocrine Societys 87th annual meeting
3. Endocrine Society and Hormone Foundation call for increased research
4. ENDO 2004, The 86th Annual Meeting of The Endocrine Society
5. Endocrine Society hosts thyroid disease audioconference
6. Endocrine Society to host audioconference on testosterone therapy for elderly men
7. The Endocrine Society responds to Institute of Medicine report on testosterone therapy for older men
8. The Gerontological Society of America announces Hartford Fellowship recipients
9. The European Society of Cardiology launches Women at Heart
10. American Thoracic Society Journal news tips for March 2005 (second issue)
11. American Thoracic Society Journal news tips for March 2005 (first issue)

Post Your Comments:
(Date:7/28/2014)... (PRWEB) July 29, 2014 ... in Situ Hybridization, Digital pathology & Workflow, ... Lymphoma, Prostate Cancer, Non Small Cell Lung ... End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract ... (The Americas, Europe, BRIC, Japan & RoW) ...
(Date:7/28/2014)... A lush green lawn offers the perfect setting for ... summer heat, lack of rain, foot traffic, and insects can ... The Grounds Guys recommends these suggestions for nurturing your summer ... week and set the height on the lawn mower about ... from heat and allows roots to retain water and grow ...
(Date:7/28/2014)... MI (PRWEB) July 28, 2014 UHY ... introduces the latest edition of UHY International Business – ... by our members, on the most current business challenges ... the world. Issue 29 covers the following topics:, ... Which industry sectors will thrive over the next five ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... A revised version of a surgical procedure to treat ... more than 90 percent of the time in patients ... the MGH Division of Plastic and Reconstructive Surgery report ... the non-endoscopic procedure all of whom had headaches ... symptom relief a year later. The team,s paper ...
Breaking Medicine News(10 mins):Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:Nurturing Lawns in the Summer Heat: The Grounds Guys® Offers Tips on Caring for Lawns This Summer 2Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2
(Date:7/28/2014)... 28, 2014 Concord Medical Services Holdings Limited ... ), a leading specialty hospital management solution provider and ... imaging centers in China , today ... Directors declared a special cash dividend of US$0.30 per ... on the Company,s outstanding ordinary shares. The total expense ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
(Date:7/28/2014)... CARLSBAD, Calif. , July 28, 2014  Isis ... following webcast:What:Isis Pharmaceuticals, Second Quarter 2014 Financial Results and ... / 7:30 a.m. PTWhere: www.isispharm.com How:Live on the ... you are unable to participate during the live event, ... a limited time at www.isispharm.com . ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
Cached News: